SlideShare ist ein Scribd-Unternehmen logo
1 von 30
Gestational Diabetes Mellitus
Sunil Kumar Daha
Introduction
“Carbohydrate intolerance of variable severity with onset or
first recognition during the present pregnancy”
• Usually presents in late 2nd or during 3rd trimester.
• >50% GDM ultimately develops to overt diabetes by next
15-20 yrs
Carbohydrate intolerance. WHY ?
• Normal pregnancy - mild fasting hypoglycemia,
postprandial hyperglycemia, and hyperinsulinemia
Pregnancy
Elevated
CRP
IL-6
GH
CTRH
HPL
Progesterone
FFA
Placenta
Insulin antagonism
and resistance
• Metabolic Changes Necessary ?? WHY ??
• Positive family history of diabetes
• Previous birth of an overweight baby of ≥4 kg
• Previous stillbirth with pancreatic islet hyperplasia
• Unexplained perinatal loss
• Polyhydramnios or recurrent vaginal candidiasis in present
pregnancy
• Age over 30 years
• Obesity - Diabesity
• Persistent glycosuria
• Ethnic group (East Asian, Pacific island ancestry)
Screening: 50g, 1hr oral glucose challenge test
• 1 hr glucose measured
• Cutoff 140 mg/dL
• Time of day, Last meal do not count.
If sensitive consider 100gm (WHO-75 gm) oral glucose
tolerance test.
Low risk group
Average risk group
High risk group
• Oral glucose load= 100gm (WHO- 75 gm)
Time Venous Plasma (mg/dl)
Fasting ≥ 95 but <126 at any
Gestational age
1 hour >180
2 hours >155
3 hours >145
O’Sullivan and Mahan modified by Carpenter and Coustan
• Symptoms of diabetes or Random Plasma
Glucose concentration of 200 mg/dl or more
According to American Diabetic Association
Time Venous Plasma (mg/dl)
Fasting ≥126 mg/dl
2 hr postprandial ≥200 mg/dl
HbA1C ≥6.5%
• Explains how pregnancy makes complication even worst
compared to nonpregnant state.
• Insulin antagonism  increased insulin demand.
• “Accelerated Starvation” : pregnancy-induced switch in
fuels from glucose to lipids.
• Hyperemesis + Sympathomimetics + corticosteroids 
Ketoacidosis
• More complicated vasculopathy.
• Explains simply the complication of diabetes
(Hyperglycemia and adverse pregnancy
outcome)
1) Maternal
2) Fetal and Neonatal
During pregnancy
• Abortion
• Preterm labor (20%)
• Infection (UTI and Vulvo-vaginitis)
• Increased incidence of preeclampsia (25%)
• Polyhydramnios (25-50%)
• Maternal distress
• Ketoacidosis and vascular changes
3
Ps
During labour:
• Prolongation of labor due to big baby
• Shoulder dystocia
• Perineal injuries
• Post partum haemorrhage
• Operative interference
During puerpurium:
• Puerperal sepsis
• Lactation failure
• Congenital malformations (6-10%)
• Fetal macrosomia (40-50%)
• Birth injury (brachial plexus)
• Intrauterine fetal death (IUFD)
• Growth restriction
• Hypoglycemia
• Respiratory distress syndrome
• Hyperbilirubinemia (25-50%)
• Polycythemia
• Hypocalcemia (<7 mg/dl)
• Hypomagnesemia (<7 mg/dl)
• Cardiomyopathy
• Long term effects: childhood obesity, neuropsychological
effects and diabetes
CNS & Skeletal CVS Renal GI Others
Neural tube
defects
VSD, ASD Renal agenesis Duodenal atresia Single
umbilical
artery
Anencephaly Coarctation of
Aorta
Hydronephrosis Anorectal atresia
Microcephaly Transposition
of great
vesssels
Double ureter Omphalocele
Caudal
Regression
syndrome
Situs inversus Polycystic kidneys Tracheoesophageal
fistula
Sacral agenesis Fallots
tetralogy
Preconceptional counselling
• To achieve tight control of diabetes
• Regular monitoring of HbA1C
• Folic acid supplementation
• Appropriate advice on diet and insulin
Principles in the managements are:
• Careful antenatal supervision & glycemic control
• To find out optimum time and method of delivery
• Arrangement for care of the newborn
1. Exercise
 Improves cardiorespiratory fitness
 Improves physiological and psychological well being
of the patient
2. Glucose monitoring
 Routine check up of blood glucose level
 HbA1C at end of 1st trimester and trimonthly
thereafter (<6% is desirable)
3. Diet
 Caloric consumption should be
 30 Kcal/kg for normal weight
 24 Kcal/kg for overweight
 12 Kcal/kg for morbidly obese women
 The constituents of diet may be:
 Carbohydrates:40-50%
 Proteins: 20%
 Fat: 30-40%
 Saturated fat<10%,
3. Diet
 ↑ Complex carbohydrate (Fiber rich diet)
 Restricted cholesterol
 Avoid sugar
 Avoid hematinic and calcium supplements
4. Obstetric management:
If good glycemic control or no need of insulin,
• Women can wait for spontaneous onset of labor
• But, not to excede expected date of delivery
• Elective delivery by induction or CS if requiring insulin
or with complication
If diet modification not consistently maintain the
fasting plsma glucose levels <95 mg/dL or the 2 hour
postprandial plasma glucose <120 mg/dL
pharmacological method is recommended. (ACOG,
2013)
Insulin therapy
 Does not cross placenta.
 Starting dose is typically 0.7-1.0 units/kg/day
 Given in divided doses
 Combination of intermediate acting (isophane) and short
acting insulin.
 Subcutaneous insulin infusion by insulin pump preferred
(more physiological)
Oral hypoglycemic agents:
 Glibenclamide and metformin (biguanide) used
 Both cross placenta but no teratogenic effects
 ACOG acknowledges both drugs for first line use.
In uncomplicated cases, patient admitted at 34-36 wks
Early hospitalization facilities:
1. Stabilization of diabetes
2. Minimizes the incidence of preeclampsia,
polyhydramnios, preterm labor.
3. Good monitoring fetal wellbeing.
4. Select appropriate time & method of delivery
Induction of labor
Indications
1. Diabetic women on insulin after 38 wks
2. Women with vascular complications (Preeclampsia, IUGR) after 37
wks
Induction of labor
Methods:
1. Usual insulin dose prior the day to induction
2. No breakfast & no morning dose given on the day
3. Normal saline infused
4. Induction done by low rupture of membrane
5. Oxytocin drip
6. IV drip of 1 lt of 5% dextrose with 10 units of soluble insulin
7. Infusion rate 100-125 ml/hr (1-1.25 units/hr)
8. Blood glucose level estimated hourly
9. Epidural analgesia ideal for pain relief
10. CS if no labor within 6-8 hours or unsatisfactory progression
Cesarean section
Indications:
1. Fetal Macrosomia
2. Diabetes with complications
3. Elderly Primigravidae
4. Multigravidae with bad obstetric history
5. Preeclampsia, Polyhydramnios, Malpresentation
Procedure
• Scheduled for early morning
• Breakfast and insulin dose omitted
• Capillary blood glucose checked
• NS infusion started
• Dextrose and insulin dose as in induction method
• Prepregnant dose started after the delivery
• Epidural or spinal anesthesia better than general anesthesia
• oral feeding can be started soon after delivery
Cesarean section
Puerperium
 Antibiotics prophylactically
 Breastfeeding encouraged
 In lactating women insulin dose is lower
Care of the baby
 Kept in NICU for at least 48 hours
 Treat complications effectively if arises
 Look for congenital malformations
 Check blood glucose within 2 hours (hypoglycemia<35mg/dl)
 Should be given Vit K 1 mg IM
 Breastfeeding within 1/2 - 1 hr and repeat at 3-4 hourly to
minimize hypoglycemia
Postpartum Evaluation
• Women diagnosed with GDM should undergo evaluation with a 75g
–OGTT at 6 to 12 weeks postpartum and other intervals thereafter
(Metzger, 2007)
• Women with a history of gestational diabetes are also at risk for
cardiovascular complications associated with dyslipidemia,
hypertension, and abdominal obesity. So must be concerned and
need proper counselling for best health outcome.
Contraception
• Low-dose hormonal contraceptives may be used safely.
• Comorbid obesity, hypertension, or dyslipidemia should direct
the choice for contraception toward a method without
potential cardiovascular consequences.
• So what is the alternative ??
1. Williams Obstetrics 24th edition
2. DC Dutta’s textbook of Obstetrics, 8th edition
Gestational Diabetes Mellitus (GDM)

Weitere ähnliche Inhalte

Was ist angesagt? (20)

Caesarean section
Caesarean sectionCaesarean section
Caesarean section
 
Shoulder dystocia
Shoulder dystociaShoulder dystocia
Shoulder dystocia
 
Diabetes Mellitus in Pregnancy
Diabetes Mellitus in PregnancyDiabetes Mellitus in Pregnancy
Diabetes Mellitus in Pregnancy
 
Management of postpartum haemorrhage
Management of postpartum haemorrhageManagement of postpartum haemorrhage
Management of postpartum haemorrhage
 
Ventouse delivery
Ventouse deliveryVentouse delivery
Ventouse delivery
 
Vacuum Delivery
Vacuum DeliveryVacuum Delivery
Vacuum Delivery
 
pre eclampsia
pre eclampsiapre eclampsia
pre eclampsia
 
Retained placenta
Retained placentaRetained placenta
Retained placenta
 
Breech presentation
 Breech presentation Breech presentation
Breech presentation
 
Habitual abortion
Habitual abortionHabitual abortion
Habitual abortion
 
Pph
PphPph
Pph
 
Manual removal of placenta
Manual removal of placentaManual removal of placenta
Manual removal of placenta
 
Breech presentation
Breech presentationBreech presentation
Breech presentation
 
Antepartum haemorrhage i
Antepartum haemorrhage iAntepartum haemorrhage i
Antepartum haemorrhage i
 
Thyroid diseases in pregnancy PPT
Thyroid diseases in pregnancy PPTThyroid diseases in pregnancy PPT
Thyroid diseases in pregnancy PPT
 
03 Active management of third stage of labour
03 Active management of third stage of labour03 Active management of third stage of labour
03 Active management of third stage of labour
 
Hyperemesis gravidarum and its management
Hyperemesis gravidarum and its managementHyperemesis gravidarum and its management
Hyperemesis gravidarum and its management
 
Induction of labor
Induction of laborInduction of labor
Induction of labor
 
Complications of puerperium
Complications of puerperiumComplications of puerperium
Complications of puerperium
 
HYPEREMESIS GRAVIDARUM
HYPEREMESIS GRAVIDARUMHYPEREMESIS GRAVIDARUM
HYPEREMESIS GRAVIDARUM
 

Ähnlich wie Gestational Diabetes Mellitus (GDM)

Gestational Diabetes Mellitus
Gestational Diabetes MellitusGestational Diabetes Mellitus
Gestational Diabetes Mellitusyashaswi pathak
 
Diabetes in pregnancy
Diabetes in pregnancyDiabetes in pregnancy
Diabetes in pregnancyBrian Shiluli
 
GDM .pptx
GDM .pptxGDM .pptx
GDM .pptxOBGSMC
 
Diabetes in pregnancy
Diabetes in pregnancy Diabetes in pregnancy
Diabetes in pregnancy Kishore Rajan
 
Diabetes in pregnancy segamat 2012
Diabetes in pregnancy segamat 2012Diabetes in pregnancy segamat 2012
Diabetes in pregnancy segamat 2012Dr Zharifhussein
 
Diabetes in Pregnancy.pptx
Diabetes in Pregnancy.pptxDiabetes in Pregnancy.pptx
Diabetes in Pregnancy.pptxDhevRavinderan1
 
diabetes in pregnancy
diabetes in pregnancydiabetes in pregnancy
diabetes in pregnancysweetututu
 
Gestational diabetes mellitus
Gestational diabetes mellitusGestational diabetes mellitus
Gestational diabetes mellitusdr hina khudaidad
 
diabetis in pregnancy.pptx
diabetis in pregnancy.pptxdiabetis in pregnancy.pptx
diabetis in pregnancy.pptxSuryavardhan77
 
Lecture_15._Diabetes_in_Pregnancy.ppt
Lecture_15._Diabetes_in_Pregnancy.pptLecture_15._Diabetes_in_Pregnancy.ppt
Lecture_15._Diabetes_in_Pregnancy.pptLawrenceshamboko
 
Presentation 28.pptx
Presentation 28.pptxPresentation 28.pptx
Presentation 28.pptxDrTejaswini7
 
GESTATIONAL DIABETES MELLITUS
GESTATIONAL DIABETES MELLITUSGESTATIONAL DIABETES MELLITUS
GESTATIONAL DIABETES MELLITUSSangeethaVijian
 
Ruba presentation
Ruba presentationRuba presentation
Ruba presentationIndhu G.P
 
(마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수
 (마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수 (마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수
(마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수mothersafe
 
Diabetes Mellitus in Pregnancy(FPII lect, ).ppt
Diabetes Mellitus in Pregnancy(FPII lect, ).pptDiabetes Mellitus in Pregnancy(FPII lect, ).ppt
Diabetes Mellitus in Pregnancy(FPII lect, ).pptBo Win
 
Gestational diabetes mellitus
Gestational diabetes mellitusGestational diabetes mellitus
Gestational diabetes mellitusJasmi Manu
 
Revised PPT GDM- clinical and nutritional perspective.pptx
Revised PPT GDM- clinical and nutritional perspective.pptxRevised PPT GDM- clinical and nutritional perspective.pptx
Revised PPT GDM- clinical and nutritional perspective.pptxVidushRatan1
 

Ähnlich wie Gestational Diabetes Mellitus (GDM) (20)

Gestational Diabetes Mellitus
Gestational Diabetes MellitusGestational Diabetes Mellitus
Gestational Diabetes Mellitus
 
Diabetes in pregnancy
Diabetes in pregnancyDiabetes in pregnancy
Diabetes in pregnancy
 
GDM .pptx
GDM .pptxGDM .pptx
GDM .pptx
 
Diabetes in pregnancy
Diabetes in pregnancy Diabetes in pregnancy
Diabetes in pregnancy
 
Diabetes in pregnancy segamat 2012
Diabetes in pregnancy segamat 2012Diabetes in pregnancy segamat 2012
Diabetes in pregnancy segamat 2012
 
Diabetes in Pregnancy.pptx
Diabetes in Pregnancy.pptxDiabetes in Pregnancy.pptx
Diabetes in Pregnancy.pptx
 
diabetes in pregnancy
diabetes in pregnancydiabetes in pregnancy
diabetes in pregnancy
 
Diabetes&pregnancy
Diabetes&pregnancyDiabetes&pregnancy
Diabetes&pregnancy
 
Gestational diabetes mellitus
Gestational diabetes mellitusGestational diabetes mellitus
Gestational diabetes mellitus
 
diabetis in pregnancy.pptx
diabetis in pregnancy.pptxdiabetis in pregnancy.pptx
diabetis in pregnancy.pptx
 
Lecture_15._Diabetes_in_Pregnancy.ppt
Lecture_15._Diabetes_in_Pregnancy.pptLecture_15._Diabetes_in_Pregnancy.ppt
Lecture_15._Diabetes_in_Pregnancy.ppt
 
Presentation 28.pptx
Presentation 28.pptxPresentation 28.pptx
Presentation 28.pptx
 
GESTATIONAL DIABETES MELLITUS
GESTATIONAL DIABETES MELLITUSGESTATIONAL DIABETES MELLITUS
GESTATIONAL DIABETES MELLITUS
 
Ruba presentation
Ruba presentationRuba presentation
Ruba presentation
 
(마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수
 (마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수 (마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수
(마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수
 
GDM: An Update
GDM: An UpdateGDM: An Update
GDM: An Update
 
Diabetes Mellitus in Pregnancy(FPII lect, ).ppt
Diabetes Mellitus in Pregnancy(FPII lect, ).pptDiabetes Mellitus in Pregnancy(FPII lect, ).ppt
Diabetes Mellitus in Pregnancy(FPII lect, ).ppt
 
GDM
GDMGDM
GDM
 
Gestational diabetes mellitus
Gestational diabetes mellitusGestational diabetes mellitus
Gestational diabetes mellitus
 
Revised PPT GDM- clinical and nutritional perspective.pptx
Revised PPT GDM- clinical and nutritional perspective.pptxRevised PPT GDM- clinical and nutritional perspective.pptx
Revised PPT GDM- clinical and nutritional perspective.pptx
 

Mehr von sunil kumar daha

Alcoholic liver disease by Sunil Kumar Daha
Alcoholic liver disease by Sunil Kumar DahaAlcoholic liver disease by Sunil Kumar Daha
Alcoholic liver disease by Sunil Kumar Dahasunil kumar daha
 
Inorganic (non metallic) irritant Poisons by Sunil Kumar Daha
Inorganic (non metallic)  irritant Poisons by Sunil Kumar DahaInorganic (non metallic)  irritant Poisons by Sunil Kumar Daha
Inorganic (non metallic) irritant Poisons by Sunil Kumar Dahasunil kumar daha
 
Meningoencephalitis by Sunil Kumar Daha
Meningoencephalitis by Sunil Kumar DahaMeningoencephalitis by Sunil Kumar Daha
Meningoencephalitis by Sunil Kumar Dahasunil kumar daha
 
Migraine and Its management
Migraine and Its managementMigraine and Its management
Migraine and Its managementsunil kumar daha
 
Tension Type Headache (TTH)
Tension Type Headache (TTH)Tension Type Headache (TTH)
Tension Type Headache (TTH)sunil kumar daha
 
Sub Arachnoid Hemorrhage (SAH)
Sub Arachnoid Hemorrhage (SAH)Sub Arachnoid Hemorrhage (SAH)
Sub Arachnoid Hemorrhage (SAH)sunil kumar daha
 
Management of antipsychotic overdose
Management of antipsychotic overdoseManagement of antipsychotic overdose
Management of antipsychotic overdosesunil kumar daha
 
Carbonmonoxide poisioning and Its management
Carbonmonoxide poisioning and Its managementCarbonmonoxide poisioning and Its management
Carbonmonoxide poisioning and Its managementsunil kumar daha
 
Organophosphate poisoning and its management
Organophosphate poisoning and its managementOrganophosphate poisoning and its management
Organophosphate poisoning and its managementsunil kumar daha
 
Paracetamol poisoning by Sunil Kumar Daha
Paracetamol poisoning by Sunil Kumar DahaParacetamol poisoning by Sunil Kumar Daha
Paracetamol poisoning by Sunil Kumar Dahasunil kumar daha
 
Management of Febrile seizures
Management of Febrile seizuresManagement of Febrile seizures
Management of Febrile seizuressunil kumar daha
 
Management of alcohol withdrawl seizure
Management of alcohol withdrawl seizureManagement of alcohol withdrawl seizure
Management of alcohol withdrawl seizuresunil kumar daha
 
Choice of Antiepileptic drugs
Choice of Antiepileptic drugsChoice of Antiepileptic drugs
Choice of Antiepileptic drugssunil kumar daha
 
Acute management of seizure
Acute management of seizureAcute management of seizure
Acute management of seizuresunil kumar daha
 
Lymphoma by Sunil Kumar Daha (Hodgkins and Non-Hodgkins)
Lymphoma by Sunil Kumar Daha (Hodgkins and Non-Hodgkins)Lymphoma by Sunil Kumar Daha (Hodgkins and Non-Hodgkins)
Lymphoma by Sunil Kumar Daha (Hodgkins and Non-Hodgkins)sunil kumar daha
 
Approach to a patient with fever of unknown origin
Approach to a patient with fever of unknown origin Approach to a patient with fever of unknown origin
Approach to a patient with fever of unknown origin sunil kumar daha
 
Fever in a hospitalized patient and its management
Fever in a hospitalized patient and its managementFever in a hospitalized patient and its management
Fever in a hospitalized patient and its managementsunil kumar daha
 
Enteric fever and its management
Enteric fever and its managementEnteric fever and its management
Enteric fever and its managementsunil kumar daha
 

Mehr von sunil kumar daha (20)

Alcoholic liver disease by Sunil Kumar Daha
Alcoholic liver disease by Sunil Kumar DahaAlcoholic liver disease by Sunil Kumar Daha
Alcoholic liver disease by Sunil Kumar Daha
 
Inorganic (non metallic) irritant Poisons by Sunil Kumar Daha
Inorganic (non metallic)  irritant Poisons by Sunil Kumar DahaInorganic (non metallic)  irritant Poisons by Sunil Kumar Daha
Inorganic (non metallic) irritant Poisons by Sunil Kumar Daha
 
Meningoencephalitis by Sunil Kumar Daha
Meningoencephalitis by Sunil Kumar DahaMeningoencephalitis by Sunil Kumar Daha
Meningoencephalitis by Sunil Kumar Daha
 
Migraine and Its management
Migraine and Its managementMigraine and Its management
Migraine and Its management
 
Tension Type Headache (TTH)
Tension Type Headache (TTH)Tension Type Headache (TTH)
Tension Type Headache (TTH)
 
Sub Arachnoid Hemorrhage (SAH)
Sub Arachnoid Hemorrhage (SAH)Sub Arachnoid Hemorrhage (SAH)
Sub Arachnoid Hemorrhage (SAH)
 
Management of antipsychotic overdose
Management of antipsychotic overdoseManagement of antipsychotic overdose
Management of antipsychotic overdose
 
Carbonmonoxide poisioning and Its management
Carbonmonoxide poisioning and Its managementCarbonmonoxide poisioning and Its management
Carbonmonoxide poisioning and Its management
 
Organophosphate poisoning and its management
Organophosphate poisoning and its managementOrganophosphate poisoning and its management
Organophosphate poisoning and its management
 
Paracetamol poisoning by Sunil Kumar Daha
Paracetamol poisoning by Sunil Kumar DahaParacetamol poisoning by Sunil Kumar Daha
Paracetamol poisoning by Sunil Kumar Daha
 
Management of Febrile seizures
Management of Febrile seizuresManagement of Febrile seizures
Management of Febrile seizures
 
Management of alcohol withdrawl seizure
Management of alcohol withdrawl seizureManagement of alcohol withdrawl seizure
Management of alcohol withdrawl seizure
 
Choice of Antiepileptic drugs
Choice of Antiepileptic drugsChoice of Antiepileptic drugs
Choice of Antiepileptic drugs
 
Acute management of seizure
Acute management of seizureAcute management of seizure
Acute management of seizure
 
Lymphoma by Sunil Kumar Daha (Hodgkins and Non-Hodgkins)
Lymphoma by Sunil Kumar Daha (Hodgkins and Non-Hodgkins)Lymphoma by Sunil Kumar Daha (Hodgkins and Non-Hodgkins)
Lymphoma by Sunil Kumar Daha (Hodgkins and Non-Hodgkins)
 
Approach to a patient with fever of unknown origin
Approach to a patient with fever of unknown origin Approach to a patient with fever of unknown origin
Approach to a patient with fever of unknown origin
 
Fever in a hospitalized patient and its management
Fever in a hospitalized patient and its managementFever in a hospitalized patient and its management
Fever in a hospitalized patient and its management
 
Enteric fever and its management
Enteric fever and its managementEnteric fever and its management
Enteric fever and its management
 
Antimicrobial resistance
Antimicrobial resistanceAntimicrobial resistance
Antimicrobial resistance
 
Typhus and its management
Typhus and its managementTyphus and its management
Typhus and its management
 

Kürzlich hochgeladen

Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 

Kürzlich hochgeladen (20)

Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 

Gestational Diabetes Mellitus (GDM)

  • 2. Introduction “Carbohydrate intolerance of variable severity with onset or first recognition during the present pregnancy” • Usually presents in late 2nd or during 3rd trimester. • >50% GDM ultimately develops to overt diabetes by next 15-20 yrs
  • 3. Carbohydrate intolerance. WHY ? • Normal pregnancy - mild fasting hypoglycemia, postprandial hyperglycemia, and hyperinsulinemia Pregnancy Elevated CRP IL-6 GH CTRH HPL Progesterone FFA Placenta Insulin antagonism and resistance • Metabolic Changes Necessary ?? WHY ??
  • 4. • Positive family history of diabetes • Previous birth of an overweight baby of ≥4 kg • Previous stillbirth with pancreatic islet hyperplasia • Unexplained perinatal loss • Polyhydramnios or recurrent vaginal candidiasis in present pregnancy • Age over 30 years • Obesity - Diabesity • Persistent glycosuria • Ethnic group (East Asian, Pacific island ancestry)
  • 5. Screening: 50g, 1hr oral glucose challenge test • 1 hr glucose measured • Cutoff 140 mg/dL • Time of day, Last meal do not count. If sensitive consider 100gm (WHO-75 gm) oral glucose tolerance test. Low risk group Average risk group High risk group
  • 6. • Oral glucose load= 100gm (WHO- 75 gm) Time Venous Plasma (mg/dl) Fasting ≥ 95 but <126 at any Gestational age 1 hour >180 2 hours >155 3 hours >145 O’Sullivan and Mahan modified by Carpenter and Coustan
  • 7. • Symptoms of diabetes or Random Plasma Glucose concentration of 200 mg/dl or more According to American Diabetic Association Time Venous Plasma (mg/dl) Fasting ≥126 mg/dl 2 hr postprandial ≥200 mg/dl HbA1C ≥6.5%
  • 8. • Explains how pregnancy makes complication even worst compared to nonpregnant state. • Insulin antagonism  increased insulin demand. • “Accelerated Starvation” : pregnancy-induced switch in fuels from glucose to lipids. • Hyperemesis + Sympathomimetics + corticosteroids  Ketoacidosis • More complicated vasculopathy.
  • 9. • Explains simply the complication of diabetes (Hyperglycemia and adverse pregnancy outcome) 1) Maternal 2) Fetal and Neonatal
  • 10. During pregnancy • Abortion • Preterm labor (20%) • Infection (UTI and Vulvo-vaginitis) • Increased incidence of preeclampsia (25%) • Polyhydramnios (25-50%) • Maternal distress • Ketoacidosis and vascular changes 3 Ps
  • 11. During labour: • Prolongation of labor due to big baby • Shoulder dystocia • Perineal injuries • Post partum haemorrhage • Operative interference During puerpurium: • Puerperal sepsis • Lactation failure
  • 12. • Congenital malformations (6-10%) • Fetal macrosomia (40-50%) • Birth injury (brachial plexus) • Intrauterine fetal death (IUFD) • Growth restriction • Hypoglycemia • Respiratory distress syndrome • Hyperbilirubinemia (25-50%)
  • 13. • Polycythemia • Hypocalcemia (<7 mg/dl) • Hypomagnesemia (<7 mg/dl) • Cardiomyopathy • Long term effects: childhood obesity, neuropsychological effects and diabetes
  • 14. CNS & Skeletal CVS Renal GI Others Neural tube defects VSD, ASD Renal agenesis Duodenal atresia Single umbilical artery Anencephaly Coarctation of Aorta Hydronephrosis Anorectal atresia Microcephaly Transposition of great vesssels Double ureter Omphalocele Caudal Regression syndrome Situs inversus Polycystic kidneys Tracheoesophageal fistula Sacral agenesis Fallots tetralogy
  • 15. Preconceptional counselling • To achieve tight control of diabetes • Regular monitoring of HbA1C • Folic acid supplementation • Appropriate advice on diet and insulin Principles in the managements are: • Careful antenatal supervision & glycemic control • To find out optimum time and method of delivery • Arrangement for care of the newborn
  • 16. 1. Exercise  Improves cardiorespiratory fitness  Improves physiological and psychological well being of the patient 2. Glucose monitoring  Routine check up of blood glucose level  HbA1C at end of 1st trimester and trimonthly thereafter (<6% is desirable)
  • 17. 3. Diet  Caloric consumption should be  30 Kcal/kg for normal weight  24 Kcal/kg for overweight  12 Kcal/kg for morbidly obese women  The constituents of diet may be:  Carbohydrates:40-50%  Proteins: 20%  Fat: 30-40%  Saturated fat<10%,
  • 18. 3. Diet  ↑ Complex carbohydrate (Fiber rich diet)  Restricted cholesterol  Avoid sugar  Avoid hematinic and calcium supplements 4. Obstetric management: If good glycemic control or no need of insulin, • Women can wait for spontaneous onset of labor • But, not to excede expected date of delivery • Elective delivery by induction or CS if requiring insulin or with complication
  • 19. If diet modification not consistently maintain the fasting plsma glucose levels <95 mg/dL or the 2 hour postprandial plasma glucose <120 mg/dL pharmacological method is recommended. (ACOG, 2013)
  • 20. Insulin therapy  Does not cross placenta.  Starting dose is typically 0.7-1.0 units/kg/day  Given in divided doses  Combination of intermediate acting (isophane) and short acting insulin.  Subcutaneous insulin infusion by insulin pump preferred (more physiological) Oral hypoglycemic agents:  Glibenclamide and metformin (biguanide) used  Both cross placenta but no teratogenic effects  ACOG acknowledges both drugs for first line use.
  • 21. In uncomplicated cases, patient admitted at 34-36 wks Early hospitalization facilities: 1. Stabilization of diabetes 2. Minimizes the incidence of preeclampsia, polyhydramnios, preterm labor. 3. Good monitoring fetal wellbeing. 4. Select appropriate time & method of delivery
  • 22. Induction of labor Indications 1. Diabetic women on insulin after 38 wks 2. Women with vascular complications (Preeclampsia, IUGR) after 37 wks
  • 23. Induction of labor Methods: 1. Usual insulin dose prior the day to induction 2. No breakfast & no morning dose given on the day 3. Normal saline infused 4. Induction done by low rupture of membrane 5. Oxytocin drip 6. IV drip of 1 lt of 5% dextrose with 10 units of soluble insulin 7. Infusion rate 100-125 ml/hr (1-1.25 units/hr) 8. Blood glucose level estimated hourly 9. Epidural analgesia ideal for pain relief 10. CS if no labor within 6-8 hours or unsatisfactory progression
  • 24. Cesarean section Indications: 1. Fetal Macrosomia 2. Diabetes with complications 3. Elderly Primigravidae 4. Multigravidae with bad obstetric history 5. Preeclampsia, Polyhydramnios, Malpresentation
  • 25. Procedure • Scheduled for early morning • Breakfast and insulin dose omitted • Capillary blood glucose checked • NS infusion started • Dextrose and insulin dose as in induction method • Prepregnant dose started after the delivery • Epidural or spinal anesthesia better than general anesthesia • oral feeding can be started soon after delivery Cesarean section
  • 26. Puerperium  Antibiotics prophylactically  Breastfeeding encouraged  In lactating women insulin dose is lower Care of the baby  Kept in NICU for at least 48 hours  Treat complications effectively if arises  Look for congenital malformations  Check blood glucose within 2 hours (hypoglycemia<35mg/dl)  Should be given Vit K 1 mg IM  Breastfeeding within 1/2 - 1 hr and repeat at 3-4 hourly to minimize hypoglycemia
  • 27. Postpartum Evaluation • Women diagnosed with GDM should undergo evaluation with a 75g –OGTT at 6 to 12 weeks postpartum and other intervals thereafter (Metzger, 2007) • Women with a history of gestational diabetes are also at risk for cardiovascular complications associated with dyslipidemia, hypertension, and abdominal obesity. So must be concerned and need proper counselling for best health outcome.
  • 28. Contraception • Low-dose hormonal contraceptives may be used safely. • Comorbid obesity, hypertension, or dyslipidemia should direct the choice for contraception toward a method without potential cardiovascular consequences. • So what is the alternative ??
  • 29. 1. Williams Obstetrics 24th edition 2. DC Dutta’s textbook of Obstetrics, 8th edition

Hinweis der Redaktion

  1. To ensure a sustained postparandial supply to the fetus. Intolerance >> Adverse effect.
  2. Intrauterine device